Leflunomide vs methotrexate
Death · adults with renal vasculitis for maintenance therapy
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Leflunomide showed no clear difference in relapse compared with methotrexate (low certainty).
Leflunomide showed no clear difference in serious adverse events* compared with methotrexate (low certainty).
Leflunomide showed no clear difference in infection compared with methotrexate (low certainty).